Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases | Pharmaceutical Patent Analyst
Discovery of an IKK2 Site that Allosterically Controls Its Activation | bioRxiv
NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors | SpringerLink
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
NF-kB inhibitors and activators | Abcam
BET inhibitors in the treatment of hematologic malignancies: current i | OTT
The anti-tumor function of the IKK inhibitor PS1145 and high levels of p65 and KLF4 are associated with the drug resistance in nasopharyngeal carcinoma cells | Scientific Reports
New therapeutic method combined with syntheti | EurekAlert!
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic | HTML
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration - The Spine Journal
Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation | PLOS Biology
Clinical small molecules inhibitors targeting IKK complex in NF-κB pathway. | Download Scientific Diagram
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Targeting IKKα kinase to prevent tumor progression and therapy resistance
Role of IκB kinase in tumorigenesis | Future Oncology
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma | Cell Death Discovery
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2022
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets | HTML
Clinical small molecule inhibitors of cell membrane receptors in NF-kB... | Download Scientific Diagram
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis - Gynecologic Oncology
